Land: Israel
Språk: engelsk
Kilde: Ministry of Health
MEDICINAL CHARCOAL; RHUBARB; SENNAE FOLIUM; SULFUR PURIFIED
TRUPHARM MARKETING 1985 LTD.
A07BA51
TABLETS
SENNAE FOLIUM 105 MG; RHUBARB 25 MG; SULFUR PURIFIED 50 MG; MEDICINAL CHARCOAL 180 MG
PER OS
Required
F. TRENKA CHEM-PHARM FABRIC, AUSTRIA
MEDICINAL CHARCOAL, COMBINATIONS
MEDICINAL CHARCOAL, COMBINATIONS
Mild laxative, anti-flatulant.
2021-04-30
Page 1 of 4 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT EUCARBON 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 tablet contains: Senna folium 105 mg Rhubarb 25 mg Medicinal charcoal 180 mg Purified sulfur 50 mg Excipient with known effect: Each tablet contains 43.4 mg of sucrose. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Black, round tablets. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Mild laxative, anti-flatulent . 4.2 POSOLOGY AND METHOD OF ADMINISTRATION POSOLOGY Adolescents over 12 years of age, adults, elderly 1-2 tablets with or after meals with liquid up to 3 times daily to obtain a laxative and purgative effect. If a stronger laxative effect is desired, the evening dose can be increased to 3-4 tablets of the product. Herbal substance/preparation corresponding to 2.65 to 3.95 mg of hydroxyanthracene glycosides (calculated as Rhein) in one tablet. The maximum daily dose of hydroxyanthracene glycosides is 30 mg. This is equivalent to 8 tablets. The correct individual dose is the smallest required to produce a comfortable soft-formed motion. Paediatric population The use in children under 12 years of age is contraindicated (see section 4.3 Contraindications). METHOD OF ADMINISTRATION For oral use. Page 1 of 4 DURATION OF USE Use for more than 1-2 weeks requires medical supervision. If the symptoms persist during the use of the medicinal product, a doctor or a pharmacist should be consulted. See also section 4.4 Special warnings and precautions for use. 4.3 CONTRAINDICATIONS Hypersensitivity to the active substance(s) or to any of the excipients listed in section 6.1. Intestinal obstruction, acute inflammatory diseases of the intestine, abdominal pain of unknown origin. Severe disorders of water and electrolyte balance. Pregnancy and lactation (see section 4.6 and 5.3). Children under 12 years of age. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE The dose necessary for a safe effect can vary individually. The occurrence of diarrhoea is a sign of ove read_full_document